Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$1.91 USD
+0.03 (1.33%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.93 +0.03 (1.31%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Fortress Biotech, Inc. has a market cap of $55.59M, which represents its share price of $1.88 multiplied by its outstanding shares number of 29.57M. As a small-cap company, FBIO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
FBIO 1.91 +0.03(1.33%)
Will FBIO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FBIO
Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?
FBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Despite Fast-paced Momentum, Fortress Biotech (FBIO) Is Still a Bargain Stock
Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum
New Strong Sell Stocks for May 16th
Other News for FBIO
Fortress Biotech’s Subsidiary Merges with Sun Pharma
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News
Wall Street Analysts Are Bullish on Top Healthcare Picks
Fortress Biotech Reports Q1 2025 Financial Highlights
Alliance Global Partners Sticks to Its Buy Rating for Fortress Biotech (FBIO)